{
  "Symbol": "DGX",
  "AssetType": "Common Stock",
  "Name": "Quest Diagnostics Incorporated",
  "Description": "Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.",
  "CIK": "1022079",
  "Exchange": "NYSE",
  "Currency": "USD",
  "Country": "USA",
  "Sector": "LIFE SCIENCES",
  "Industry": "SERVICES-MEDICAL LABORATORIES",
  "Address": "500 PLAZA DRIVE, SECAUCUS, NJ, US",
  "OfficialSite": "https://www.questdiagnostics.com",
  "FiscalYearEnd": "December",
  "LatestQuarter": "2024-12-31",
  "MarketCapitalization": "19354278000",
  "EBITDA": "1903000000",
  "PERatio": "21.82",
  "PEGRatio": "1.465",
  "BookValue": "61.06",
  "DividendPerShare": "0",
  "DividendYield": "0.0198",
  "EPS": "7.92",
  "RevenuePerShareTTM": "88.94",
  "ProfitMargin": "0.0882",
  "OperatingMarginTTM": "0.14",
  "ReturnOnAssetsTTM": "0.0584",
  "ReturnOnEquityTTM": "0.138",
  "RevenueTTM": "9872000000",
  "GrossProfitTTM": "3271000000",
  "DilutedEPSTTM": "7.92",
  "QuarterlyEarningsGrowthYOY": "0.202",
  "QuarterlyRevenueGrowthYOY": "0.146",
  "AnalystTargetPrice": "180.74",
  "AnalystRatingStrongBuy": "1",
  "AnalystRatingBuy": "7",
  "AnalystRatingHold": "10",
  "AnalystRatingSell": "0",
  "AnalystRatingStrongSell": "0",
  "TrailingPE": "21.82",
  "ForwardPE": "16.69",
  "PriceToSalesRatioTTM": "1.96",
  "PriceToBookRatio": "2.65",
  "EVToRevenue": "2.482",
  "EVToEBITDA": "12.94",
  "Beta": "0.776",
  "52WeekHigh": "178.0",
  "52WeekLow": "131.39",
  "50DayMovingAverage": "168.61",
  "200DayMovingAverage": "157.04",
  "SharesOutstanding": "111978000",
  "DividendDate": "2025-04-21",
  "ExDividendDate": "2025-04-07",
  "Last Updated": "2025-04-23 14:46:02",
  "Price_Day_1": 172.84,
  "Price_Day_2": 161.86,
  "Price_Day_3": 163.8,
  "Price_Day_4": 164.47,
  "Price_Day_5": 167.23,
  "Price_Day_6": 168.0,
  "Price_Day_7": 163.99,
  "Income_totalRevenue_Q1": "2621000000",
  "Income_grossProfit_Q1": "858000000",
  "Income_netIncome_Q1": "222000000",
  "Income_totalRevenue_Q2": "2488000000",
  "Income_grossProfit_Q2": "811000000",
  "Income_netIncome_Q2": "226000000",
  "Income_totalRevenue_Q3": "2397000000",
  "Income_grossProfit_Q3": "776000000",
  "Income_netIncome_Q3": "229000000",
  "Income_totalRevenue_Q4": "2366000000",
  "Income_grossProfit_Q4": "755000000",
  "Income_netIncome_Q4": "194000000",
  "Balance_totalAssets_Q1": "16153000000",
  "Balance_totalLiabilities_Q1": "9257000000",
  "Balance_totalShareholderEquity_Q1": "6778000000",
  "Balance_cashAndCashEquivalentsAtCarryingValue_Q1": "549000000",
  "Balance_totalAssets_Q2": "16095000000",
  "Balance_totalLiabilities_Q2": "9174000000",
  "Balance_totalShareholderEquity_Q2": "6809000000",
  "Balance_cashAndCashEquivalentsAtCarryingValue_Q2": "764000000",
  "Balance_totalAssets_Q3": "13881000000",
  "Balance_totalLiabilities_Q3": "7146000000",
  "Balance_totalShareholderEquity_Q3": "6617000000",
  "Balance_cashAndCashEquivalentsAtCarryingValue_Q3": "271000000",
  "Balance_totalAssets_Q4": "13954000000",
  "Balance_totalLiabilities_Q4": "7408000000",
  "Balance_totalShareholderEquity_Q4": "6432000000",
  "Balance_cashAndCashEquivalentsAtCarryingValue_Q4": "474000000",
  "Debt to Equity Ratio": 1.37,
  "Is Complete": true
}